^SERIES = GSE146539
!Series_title = Genome binding/occupancy profiling of ccRCC cell line upon SETD2 rescue [ChIPseq_JHRCC12]
!Series_geo_accession = GSE146539
!Series_status = Public on Nov 15 2021
!Series_submission_date = Mar 06 2020
!Series_last_update_date = Mar 25 2022
!Series_pubmed_id = 35115713
!Series_summary = SETD2, a H3K36 trimethyltransferase, is frequently mutated in human cancers with the highest prevalence (13%) in clear cell renal cell carcinoma (ccRCC). Genomic profiling of primary ccRCC tumors reveals a positive correlation between SETD2 mutations and metastasis. However, whether and how SETD2-loss promotes metastasis remains unclear. Here, we detected SETD2 mutations in 24 of 51 (47%) metastatic ccRCC tumors. Using SETD2-mutant metastatic ccRCC patient-derived cell line and xenograft models, we showed that H3K36me3 restoration greatly reduced distant metastases of ccRCC in mice. An integrated ATAC-seq, ChIP-seq, and transcriptome analysis concluded a tumor suppressor model in which loss of SETD2-mediated H3K36me3 activates enhancers to drive oncogenic transcription through dysregulating histone chaperone recruitment, enhancing histone exchange, and expanding chromatin accessibility. Furthermore, we uncovered mechanism-based therapeutic strategies for SETD2-deficient cancer through inhibition of histone chaperones. Overall, SETD2-loss creates a permissive epigenetic landscape for cooperating oncogenic drivers to amplify transcriptional output, providing unique therapeutic opportunities.
!Series_overall_design = ChIP-Seq was performed in SETD2-proficient and SETD2-deficient JHRCC12 cells in 2 replicates.
!Series_type = Genome binding/occupancy profiling by high throughput sequencing
!Series_contributor = Yuchen,,Xie
!Series_contributor = Merve,,Sahin
!Series_contributor = Emily,H,Cheng
!Series_sample_id = GSM4391908
!Series_sample_id = GSM4391909
!Series_sample_id = GSM4391910
!Series_sample_id = GSM4391911
!Series_sample_id = GSM4391912
!Series_sample_id = GSM4391913
!Series_sample_id = GSM4391914
!Series_sample_id = GSM4391915
!Series_sample_id = GSM4391916
!Series_sample_id = GSM4391917
!Series_sample_id = GSM4391918
!Series_sample_id = GSM4391919
!Series_sample_id = GSM4391920
!Series_sample_id = GSM4391921
!Series_sample_id = GSM4391922
!Series_sample_id = GSM4391923
!Series_sample_id = GSM4391924
!Series_sample_id = GSM4391925
!Series_sample_id = GSM4391926
!Series_sample_id = GSM4391927
!Series_sample_id = GSM4391928
!Series_sample_id = GSM4391929
!Series_sample_id = GSM4391930
!Series_sample_id = GSM4391931
!Series_sample_id = GSM4391932
!Series_sample_id = GSM4391933
!Series_contact_name = Christina,S,Leslie
!Series_contact_department = Computational Biology Program
!Series_contact_institute = Memorial Sloan Kettering Cancer Center
!Series_contact_address = 417 E 68th St
!Series_contact_city = New York
!Series_contact_state = NY
!Series_contact_zip/postal_code = 10065
!Series_contact_country = USA
!Series_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE146nnn/GSE146539/suppl/GSE146539_RAW.tar
!Series_platform_id = GPL16791
!Series_platform_organism = Homo sapiens
!Series_platform_taxid = 9606
!Series_sample_organism = Homo sapiens
!Series_sample_taxid = 9606
!Series_relation = SubSeries of: GSE146583
!Series_relation = BioProject: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA610879
!Series_relation = SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRP251918
